The Indiana Diabetes Research Center has a very broad focus on basic science and translational research with a key strength in cell biology, molecular metabolism, & islet function. Their partnerships have allowed them to broaden this research and develop translational research into new diagnostics & therapeutics.
William C. Hsu 先生
Joslin Diabetes Center
Harvard Medical School
Mark Creager, MD, president of the American Heart Association and Bob Bonow, MD and Elliott Antman, MD, both past presidents, discuss the Atrial Fibrillation and Pacing science presented in Hotline II at the European Society of Cardiology Congress 2015 in London, including LEADLESS II and BELIEF.
ADA TV was pleased to talk to the American Diabetes Association’s CEO, Kevin L. Hagan, about some exciting new initiatives underway.
Washington University and St. Louis Children’s Hospital are among the premier national institutions providing exceptional research, patient care and clinical training to impact the lives of all children with diabetes. The school has a longstanding history of major contributions to the field of endocrinology. This highly collaborative and integrative academic environment and strong infrastructure provides enhanced options for collaboration between basic science and clinical disciplines putting Washington University at the forefront for scientific discovery and treatment of endocrine diseases. Highlights of the institutional strengths include the Wolfram Syndrome International Registry and one of the largest medical scientist training programs.
Group entry to the 2015 Diabetes in School Short Film Competition, made by Abby, Eleanor, Ellie, Remi and Nathaniel from Unsworth, Bury.
Find our more about our Make the Grade campaign www.diabetes.org.uk/make-the-grade/
Elliott Antman, MD, president of the American Heart Association, Clyde Yancy, MD, past president, and Eric Peterson, MD discuss the potential clinical impact of the science presented at the American College of Cardiology 2015 in San Diego.
Zorina Galis, PhD, Chief of the NHLBI Vascular Biology and Hypertension Research Branch, and Muredach Reilly, MBBCH, MSCE, program chair for ATVB/PVD 2015, provide expert perspectives on the science presented at the meeting this year in San Francisco, with an emphasis on a number of opportunities during the meeting for spurring the translation basic ATVB and PVD science into new therapies for patients.
昭和大学医学部内科学講座 糖尿病・代謝・内分泌内科学部門 主任教授 平野 勉先生
いしい医院 院長 石井 誠先生
Elliott Antman, MD, president of the American Heart Association, Kathryn J. Moore, PhD, chair of the council for ATVB, Michael Conte, MD, chair of the council for PVD, and Muredach P. Reilly, MBBCH, MSCE, program chair discuss the exciting science they have planned for the meeting in San Francisco this year.